Features
Jack Goddard investigates how the COVID-19 pandemic has disrupted R&D, and how the changes it enforced may prevent such...
As NICE approves the most expensive drug ever for use by the NHS, Jack Goddard takes a look at drug pricing in the UK, how it...
Clinical trials are immensely valuable in establishing the safety and effectiveness of a drug in carefully selected participants, but what we can...
Early and managed access programmes provide opportunities for patients to get the treatments they need faster - but the COVID-19 pandemic has...
The race to provide vaccines and treatments for coronavirus has seen a number of COVID-19 drugs reach the market in record time. Darcy Jimenez...
In its disruption to clinical trials and drug supply to patients, the COVID-19 pandemic has impacted the most crucial areas of the cancer drugs...
Matt Fellows explores how early and managed access schemes are mutually beneficial to sponsors and patients alike, as well as how to...
Diabetic patients face daily challenges of treatment access and treatment management, so 2020 has been a particularly challenging year. Conor...
Democratic presidential nominee, and former Vice-President, Joe Biden and President Donald Trump have two drastically different visions for the...
Thirteen-year-old Calvin Muir lives with the ultra-rare genetic condition Timothy syndrome. Like many parents of rare disease patients, his mother...